R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium

Journal of Neurochemistry

Volumn 70, Issue 2, 1998, Pages 515-523

  Paterson, I A ^a   Zhang, D ^a   Warrington, R C ^b   Boulton, A A ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Aliphatic propargylamines; Cerebellar granule cells; Deprenyl; Mitochondria; Neuronal apoptosis; p53

Indexed keywords

2 HEPTYL N METHYLPROPARGYLAMINE; CYTARABINE; MONOAMINE OXIDASE B INHIBITOR; POTASSIUM ION; PROTEIN P53; SELEGILINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN MITOCHONDRION; CELL PROTECTION; CONTROLLED STUDY; GRANULE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; ARA;

EID: 0031914155     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70020515.x     Document Type: Article

References (43)

1. Ansari K. S., Yu P. H., Kruck T. Y., and Tatton W. G. (1993) Death of axotomised immature rat facial motor neurons: stereospecific rescue by R(-)deprenyl independently of MAO inhibition. J. Neurosci. 13, 4042-4053.
2. Berry M. D., Juorio A. V., and Paterson I. A. (1994) Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders. Prog. Neurobiol. 44, 141-161.
3. Boulton A. A., Yu P. H., Davis B. A., Paterson I. A., Li X., Juorio A. V., Durden D. A., and Dyck L. E. (1998) Aliphatic N-methylpropargylamines: MAO-B inhibitors and antiapoptotic drugs. Adv. Pharmacol. 42, 308-311.
4. Chen J., Zhu R. L., Nakayama M., Kawaguchi K., Jin K., Stetler R. A., Simon R. P., and Graham S. H. (1996) Expression of the apoptosis effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischaemia. J. Neurochem. 67, 64-71.
5. Clarke A. R., Purdie C. A., Harrison D. J., Morris R. G., Bird C. C., Hooper M. L., and Wyllie A. H. (1993) Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362, 849-852.
6. Crumrine R. C., Thomas A. L., and Morgan P. F. (1994) Attenuation of p53 expression protects against focal ischaemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14, 887-891.
7. Dessi F., Pollard H., Moreau J., Ben-Ari Y., and Charriaut-Marlangue C. (1995) Cytosine arabinoside induces apoptosis in cerebellar neurons in culture. J. Neurochem. 64, 1980-1987.
8. D'Mello S. R., Galli C., Ciotti T., and Calissano P. (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA 90, 10989-10993.
9. Enokido Y., Araki T., Aizawa S., and Hatanaka H. (1996a) p53 involves cytosine arabinoside-induced apoptosis in cultured cerebellar granule neurons. Neurosci. Lett. 203, 1-4.
10. Enokido Y., Araki T., Tanak K., Aizawa S., and Hatanaka H. (1996b) Involvement of p53 in DNA strand break-induced apoptosis in post-mitotic CNS neurones. Eur. J. Neurosci. 8, 1812-1821.
11. Fang J., Zuo D. M., and Yu P. H. (1995) Lack of protective effect of R(-)deprenyl on programmed cell death of mouse thymocytes induced by dexamethasone. Life Sci. 57, 15-22.
12. Ishitani R. and Chuang D.-M. (1996) Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinoside-induced apoptosis in cultured cerebellar neurons. Proc. Natl. Acad. Sci. USA 93, 9937-9941.
13. Jordán J., Galindo M. F., Prehn J. H. M., Weichselbaum R. R., Beckett M., Ghadge G. D., Roos R. P., Leiden J. M., and Millar R. J. (1997) p53 expression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci. 17, 1397-1405.
14. Kluck R. M., Bossy-Wetzel E., Green D. R., and Newmeyer D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
15. Li X.-M., Juorio A. V., and Boulton A. A. (1995) Some new mechanisms underlying the actions of (-)deprenyl: possible relevance to neurodegeneration. Prog. Brain Res. 106, 99-112.
16. Liu X., Kim C. N., Yang J., Jemmerson R., and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome C. Cell 86, 147-157.
17. Miyashita T., Krajewski S., Krajewska M., Wang H. G., Lin H. K., Liebermann D. A., Hoffman B., and Reed J. C. (1994) Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
18. Mytilineou C., Radcliffe P. M., Leonardi E. K., Werner P., and Olanow C. W. (1997b) L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro. J. Neurochem. 68, 33-39.
19. Mytilineou C., Radcliffe P. M., and Olanow C. W. (1997b) L-(-)-Desmethylselegiline, a metabolite of selegiline [L-(-)-deprenyl], protects mesencephalic dopamine neurons from excitotoxicity in vitro. J. Neurochem. 68, 434-436.
20. Nardi N., Avidan G., Daily D., Zilkha-Falb R., and Barzilai A. (1997) Biochemical and temporal analysis of events associated with apoptosis induced by lowering the extracellular potassium concentration in mouse cerebellar granule neurons. J. Neurochem. 68, 750-759.
21. Paterson I. A. and Tatton W. G. (1998) Anti-apoptotic actions of MAO-B inhibitors. Adv. Pharmacol. 42, 312-315.
22. Paterson I. A., Barber A. J., Gelowitz D. L., and Voll C. L. (1997a) (-)Deprenyl reduces delayed neuronal death of hippocampal pyramidal cells. Neurosci. Biobehav. Dev. 21, 181-186.
23. Paterson I. A., Davis B. A., Durden D. A., and Boulton A. A. (1997b) Aliphatic propargylamines prevent hippocampal neuronal death induced by hypoxia-ischaemia. (Abstr.) J. Neurochem. 69 (Suppl.), S137A.
24. Paterson I. A., Dyck L. E., Durden D. A., Davis B. A., Liu Y., and Boulton A. A. (1997c) The antiapoptotic effect of 2HMP is due to a desmethyl metabolite. Soc. Neurosci. Abstr. 23, 880.6.
25. Robinson B. J. (1985) Stereoselectivity and isoenzyme selectivity of monoamine oxidase inhibitors: enantiomers of amphetamine, N-methylamphetamine and deprenyl. Biochem. Pharmacol. 34, 4105-4108.
26. Roy E. and Bedard P. J. (1993) Deprenyl increases survival of rat foetal nigral neurons in culture. Neuroreport 4, 1183-1186.
27. Sakhi S. and Schreiber S. S. (1997) p53 induction is a marker of neuronal apoptosis in the central nervous system, in Neuromethods, Vol. 29: Apoptosis Techniques and Protocols (Poirier J., ed), pp. 85-98. Humana Press, Totowa, New Jersey.
28. Salo P. T. and Tatton W. G. (1992) Deprenyl reduces the death of motoneurons caused by axotomy. J. Neurosci. Res. 31, 394-400.
29. Susin S. A., Zamzami N., Castedo M., Hirsch T., Marchetti P., Macho A., Daugas E., Geuskens M., and Kroemer G. (1996) Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331-1341.
30. Tatton W. and Chalmers-Redman R. M. E. (1996) Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology 47 (Suppl. 3), S171-S183.
31. Tatton W. G. and Greenwood C. (1991) Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res. 30, 666-672.
32. Tatton W. G., Ju W. Y. L., Holland D. P., Tai C., and Kwan M. (1994) (-)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J. Neurochem. 63, 1572-1575.
33. Taylor J., Gatchalian C. L., Keen G., and Rubin L. L. (1997) Apoptosis in cerebellar granule neurones: involvement of interleukin-1β converting enzyme-like proteases. J. Neurochem. 68, 1598-1605.
34. Villalba M., Bockaert J., and Journot L. (1997) Concomitant induction of apoptosis and necrosis in cerebellar granule cells following serum and potassium withdrawal. Neuroreport 8, 981-985.
35. Yan G.-M. and Paul S. M. (1997) Cultured cerebellar granule neurons as a model of neuronal apoptosis, in Neuromethods, Vol. 29: Apoptosis Techniques and Protocols (Poirier J., ed), pp. 47-66. Humana Press, Totowa, New Jersey.
36. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T.-I., Jones D. P., and Wang X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
37. Yu P. H., Davis B. A., and Boulton A. A. (1992a) Aliphatic propargylamines: potent, selective, irreversible MAO-B inhibitors. J. Med. Chem. 35, 3705-3713.
38. Yu P. H., Davis B. A., and Boulton A. A. (1992b) Aliphatic propargylamines as specific MAO-B inhibitors. U.S. patent 5,169,868.
39. Yu P. H., Davis B. A., and Boulton A. A. (1993) Effect of structural modification of alkyl N-propargylamines on the selective inhibition of MAO-B activity. Biochem. Pharmacol. 46, 753-757.
40. Yu P. H., Davis B. A., Durden D. A., Barber A., Terleckyj I., Nicklas W. G., and Boulton A. A. (1994) Neurochemical and neuroprotective effects of some aliphatic propargylamines: new, selective nonamphetamine-like MAO-B inhibitors. J. Neurochem. 62, 697-704.
41. Yu P. H., Davis B. A., Zhang X., Zuo D.-M., Fang J., Lai C.-T., Li X.-M., Paterson I. A., and Boulton A. A. (1995) Neurochemical, neuroprotective and neurorescue effects of aliphatic N-methylpropargylamines: new MAO-B inhibitors without amphetamine-like properties. Prog. Brain Res. 106, 113-121.
42. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssière J.-L., Petit P. X., and Kroemer G. (1995) Reduction of mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181, 1661-1672.
43. Zhang X., Boulton A. A., and Yu P. H. (1996) Expression of heat shock protein-70 and limbic seizure-induced neuronal death in the rat brain. Eur. J. Neurosci. 8, 1432-1440.